Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rayan Bou Fakhredin

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Hematology/Oncology Clinics of North America|March 12, 2023
Clinical Complications and Their ManagementRayan Bou-Fakhredin, Irene Motta, Maria Domenica Cappellini, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|December 21, 2023
Unmet needs in β-thalassemia and the evolving treatment landscapeRyan Njeim, Bilal Naouss, Rayan Bou-Fakhredin, et al.
American Journal of Hematology|August 4, 2021
2021 update on clinical trials in β-thalassemiaKhaled M Musallam, Rayan Bou-Fakhredin, Maria Domenica Cappellini, et al.
Hemoglobin|March 2, 2018
Hepatocellular Carcinoma in a β-Thalassemia Intermedia Patient: Yet Another Case in the Expanding EpidemicHassan M Moukhadder, Joseph E Roumi, Rayan Bou-Fakhredin, et al.
American Journal of Hematology|October 14, 2024
Hypercoagulability in hemoglobinopathies: Decoding the thrombotic threatRayan Bou-Fakhredin, Maria Domenica Cappellini, Ali T Taher, et al.
Expert Review of Hematology|September 8, 2021
Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategiesAli T Taher, Rayan Bou-Fakhredin, Antonis Kattamis, et al.
British Journal of Haematology|December 16, 2024
Reframing thalassaemia syndrome as a benign haematopoietic stem cell disorderAurelio Maggio, Mariasanta Napolitano, Ali T Taher, et al.
Expert Review of Hematology|September 15, 2020
COVID-19 in benign hematology: emerging challenges and special considerations for healthcare professionalsPeter Noun, Ahmad Ibrahim, Mohammad Hassan Hodroj, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated PerspectiveRayan Bou-Fakhredin, Lucia De Franceschi, Irene Motta, et al.
Hematology/Oncology Clinics of North America|February 21, 2018
Hypercoagulability and Vascular DiseaseAli T Taher, Maria Domenica Cappellini, Rayan Bou-Fakhredin, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Hematology/Oncology Clinics of North America|March 12, 2023
Clinical Complications and Their ManagementRayan Bou-Fakhredin, Irene Motta, Maria Domenica Cappellini, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|December 21, 2023
Unmet needs in β-thalassemia and the evolving treatment landscapeRyan Njeim, Bilal Naouss, Rayan Bou-Fakhredin, et al.
American Journal of Hematology|August 4, 2021
2021 update on clinical trials in β-thalassemiaKhaled M Musallam, Rayan Bou-Fakhredin, Maria Domenica Cappellini, et al.
Hemoglobin|March 2, 2018
Hepatocellular Carcinoma in a β-Thalassemia Intermedia Patient: Yet Another Case in the Expanding EpidemicHassan M Moukhadder, Joseph E Roumi, Rayan Bou-Fakhredin, et al.
American Journal of Hematology|October 14, 2024
Hypercoagulability in hemoglobinopathies: Decoding the thrombotic threatRayan Bou-Fakhredin, Maria Domenica Cappellini, Ali T Taher, et al.
Expert Review of Hematology|September 8, 2021
Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategiesAli T Taher, Rayan Bou-Fakhredin, Antonis Kattamis, et al.
British Journal of Haematology|December 16, 2024
Reframing thalassaemia syndrome as a benign haematopoietic stem cell disorderAurelio Maggio, Mariasanta Napolitano, Ali T Taher, et al.
Expert Review of Hematology|September 15, 2020
COVID-19 in benign hematology: emerging challenges and special considerations for healthcare professionalsPeter Noun, Ahmad Ibrahim, Mohammad Hassan Hodroj, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated PerspectiveRayan Bou-Fakhredin, Lucia De Franceschi, Irene Motta, et al.
Hematology/Oncology Clinics of North America|February 21, 2018
Hypercoagulability and Vascular DiseaseAli T Taher, Maria Domenica Cappellini, Rayan Bou-Fakhredin, et al.
Pageof 4